XFOR
X4 Pharmaceuticals, Inc
NASDAQ · Healthcare · Biotechnology · US
$2.75
+6.18%Oct 8, 2026, 11:00 UTC
X4 Pharmaceuticals, Inc entered into a senior secured term loan facility of up to $150 million with K2 HealthVentures, replacing its prior loan agreement.
Source:Aug 6, 2026, 20:15 UTC
X4 Pharmaceuticals reported financial results for the second quarter ended June 30, 2026.
Source:Jul 1, 2026, 11:00 UTC
X4 Pharmaceuticals appointed Kelly Gold to its Board of Directors as an independent director and member of the Audit Committee, effective July 1, 2026.
Source: